Perceptive Advisors - BRIDGEBIO PHARMA INC ownership

BRIDGEBIO PHARMA INC's ticker is BBIO and the CUSIP is 10806X102. A total of 180 filers reported holding BRIDGEBIO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of BRIDGEBIO PHARMA INC
ValueSharesWeighting
Q3 2023$46,119,363
+53.3%
1,748,9330.0%1.54%
+76.6%
Q2 2023$30,081,647
-4.9%
1,748,933
-8.3%
0.87%
-6.7%
Q1 2023$31,618,607
+144.5%
1,907,033
+12.4%
0.93%
+157.3%
Q4 2022$12,931,391
-23.3%
1,697,0330.0%0.36%
-25.9%
Q3 2022$16,869,000
+9.5%
1,697,0330.0%0.49%
+1.4%
Q2 2022$15,409,000
-60.5%
1,697,033
-55.8%
0.48%
-38.2%
Q1 2022$38,969,000
-83.6%
3,839,380
-73.1%
0.78%
-57.4%
Q4 2021$237,814,000
-34.6%
14,257,510
+83.8%
1.83%
-65.3%
Q3 2021$363,567,000
-61.6%
7,756,928
-50.0%
5.28%
-14.0%
Q2 2021$945,724,000
+97.9%
15,513,856
+100.0%
6.14%
+1.6%
Q1 2021$477,827,000
+0.2%
7,756,928
+15.7%
6.04%
+18.1%
Q4 2020$476,883,000
+89.5%
6,706,2680.0%5.12%
+39.3%
Q3 2020$251,619,000
+15.1%
6,706,2680.0%3.67%
+3.6%
Q2 2020$218,691,000
+12.4%
6,706,2680.0%3.54%
-30.0%
Q1 2020$194,481,000
+36.7%
6,706,2680.0%5.06%
+79.2%
Q4 2019$142,273,000
-1.2%
6,706,2680.0%2.83%
-27.1%
Q3 2019$143,983,000
-20.4%
6,706,2680.0%3.88%
-6.5%
Q2 2019$180,868,0006,706,2684.15%
Other shareholders
BRIDGEBIO PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 6,068,125$160,016,45665.94%
Kohlberg Kravis Roberts & Co. L.P. 31,060,971$819,077,80528.79%
Cormorant Asset Management, LP 4,662,530$122,950,9167.17%
Frazier Life Sciences Management, L.P. 2,725,949$71,883,2754.77%
Octagon Capital Advisors LP 971,639$25,622,1203.94%
M28 Capital Management LP 121,200$3,196,0443.66%
VIKING GLOBAL INVESTORS LP 25,120,991$662,440,5332.69%
BOONE CAPITAL MANAGEMENT LLC 313,381$8,263,8572.61%
Fernwood Investment Management, LLC 235,620$6,213,2992.23%
SOUTHPORT MANAGEMENT, L.L.C. 15,000$395,5502.15%
View complete list of BRIDGEBIO PHARMA INC shareholders